combination of disulfiram and copper gluconate

combination of disulfiram and copper gluconate
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2016-05-18 00:00:00
Sponsor Cantex Pharmaceuticals, Inc.;1792 Bell Tower Lane;Weston, Florida, 33326
Related Access Program
Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM